ArticleRedox biology2026

A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.

Yiming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.